Avidity Partners Management LP Fusion Pharmaceuticals Inc. Transaction History

Avidity Partners Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.48 - $9.65 $1.78 Million - $6.93 Million	718,478 Added 12.43%	6,500,328 $62.5 Million
Q3 2023 Nov 14, 2023	BUY	$2.37 - $4.63 $193,984 - $378,965	81,850 Added 1.44%	5,781,850 $15 Million
Q1 2023 May 15, 2023	BUY	$3.03 - $5.13 $17.3 Million - $29.2 Million	5,700,000 New	5,700,000 $21.5 Million
Q3 2020 Nov 16, 2020	SELL	$11.8 - $17.1 $1.94 Million - $2.81 Million	-164,554 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.0 - $17.78 $2.8 Million - $2.93 Million	164,554 New	164,554 $2.88 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.